| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |